The board of directors of the China NT Pharma Group Company Limited announced that based on a preliminary review of the Group's unaudited management accounts and the information currently available to the Board, the Board currently estimates that the Group will likely record a loss for the year ended 31 December 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.026 HKD | +4.00% | 0.00% | -52.73% |
28/03 | China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
15/01 | China NT Pharma Group Company Limited Announces Directorate Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-52.73% | 87.89L | |
+18.04% | 4.29TCr | |
+16.92% | 2.14TCr | |
+18.33% | 1.51TCr | |
+19.27% | 1.44TCr | |
+56.12% | 1.3TCr | |
-0.05% | 678.76Cr | |
-10.73% | 672.16Cr | |
-8.87% | 572.55Cr | |
+11.21% | 546.52Cr |
- Stock Market
- Equities
- 1011 Stock
- News China NT Pharma Group Company Limited
- China NT Pharma Group Company Limited Provides Group Earnings Guidance for the Full Year Ended 31 December 2013